CXCL12 and myocardial infarction: Previous studies assessing circulating SDF-1α levels as a prognostic indicator in CAD patients have shown that its elevation was associated with increased risk of adverse cardiovascular events, including myocardial infarction and CV mortality in chronic coronary syndrome patients and ACS patients [12–14].